Chinese authorities from the National Health Commission have reported an increase in incidence of respiratory diseases in China.
Jiangsu Hengrui, a preferred China partner for U.S. biotech, hints at more deals
SAN FRANCISCO — One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui Pharmaceuticals, emphasized its global ambitions and plans for more dealmaking at